The News
Myriad Group Reports EBITDA of USD 11 Million for 2009 H1
23/09/2009
DUEBENDORF-ZURICH, Switzerland – 23 September 2009 – Myriad Group AG (SIX: MYRN), a global leader in mobile technology with software in over 2 billion phones, today reported its results for the first half of 2009.
• Pro forma revenues USD 62.7 million, up 215% from 2008 H1 (1)
• Gross profit margin of 61%, up 7 pct points
• EBITDA USD 11.0 million (before restructuring charges)
• Operating cash flow of USD 2.7 million
• Cash & cash equivalents of USD 21.7 million
“I am very pleased with the progress of the new company during this first half,” said Simon Wilkinson, CEO of Myriad. “We closed the acquisition of Purple Labs, delivered the cost synergies of the integrated companies, and achieved the strong revenue and margins that we expected in bringing these companies together – all contributing to the rapid improvement in our EBITDA result.
“We are now looking to build on this momentum as we prepare for 2010. Given the depth of our portfolio and team, Myriad is well positioned to extend both its market leadership and profitability.”
(1) Pro forma financial information disclosed in this news release reflects the entire Group’s financial results for the first six months of 2009, as if Myriad’s acquisition of Purple Labs had closed on 1 January 2009.
Myriad believes that pro forma financial information provides more meaningful period-to-period comparisons of its performance, as under IFRS Purple Labs results have only been consolidated since April 1, 2009. For more information, see the financial statements for the six months period ended June 30 on the company’s website.
Details of half-year 2009 results, pro forma (1)
Revenue for the first half of 2009 reached USD 62.7 million, an increase of 215% compared to USD 19.9 million in the first half of 2008.
The Device Solutions segment – which provides software and engineering services to leading manufacturers of mobile phones and other devices – reported revenue of USD 55.2 million for 2009 H1, compared to USD 11.4 million in 2008 H1.
Revenue growth in 2009 primarily resulted from the acquisitions of Sagem Mobiles software activities and Purple Labs, although underlying demand for Myriad device software and services continues to be robust, with the company recording USD 23.4 million in new orders during the 6-month period.
The Mobile Services Platforms segment – which provides self-care services and other solutions for mobile network operators – reported revenue of USD 7.5 million in 2009 H1. The decline from USD 8.5 million in the prior year period reflects the global slowdown in infrastructure investment by mobile network operators in 2009. Nonetheless, Myriad added T-Mobile and three other new operator customers in the first six months of 2009, and retained its industryleading market share with a customer base of 33 network operators worldwide.
Gross profit increased 259% to USD 38.4 million for 2009 H1, from USD 10.7 million in 2008 H1. Lifted by the increased scale and efficiencies of the combined company, gross margin also rose sharply, reaching 61% compared to 54% in the year ago period.
Underlying operating profit (2) increased to USD 11.0 million for the first half of 2009, delivering an underlying operating profit margin of 18%. In 2008 H1, EBITDA was reported at USD 0.6 million with 3% profit margin.
(2) Pro forma EBITDA excluding any costs associated with restructuring and impairment of intangible assets including goodwill. Myriad considers this Underlying Operating Profit to be an important indicator of the operational strength of the business.
The underlying operating profit in 2009 H1 is the best ever recorded by the company, and again reflects the increased scale and efficiencies resulting from the integration of Purple Labs.
Sales and marketing expense for the combined company was USD 5.4 million in 2009 H1, down slightly from USD 5.5 million in 2008 H1. As a percent of revenue, sales and marketing expense was reduced to 9%, compared to 28% in the prior year period.
General and administrative (G&A) expense also was reduced as a percent of revenue, from 18% in 2008 H1 to 15% in 2009 H1.
These efficiencies in sales, marketing and G&A allowed the combined company to increase its research and development (R&D) costs, net of capitalisation, to USD 15.7 million in 2009 H1 from USD 2.0 million in 2008 H1. Myriad expects that this greater emphasis on R&D activity will accelerate the introduction of new products and resulting growth.
Operating Loss (EBIT) before Exceptional Charges improved to USD 1.5 million in 2009 H1 compared to USD 2.2 million in 2008 H1, despite increased amortisation following the acquisitions of Sagem Mobiles software activities and Purple Labs. Amortisation of intangible assets was USD 12.1 million in 2009 H1 compared to USD 2.6 million in the year earlier period. Exceptional charges during the first half of 2009 included restructuring costs related to the acquisitions and impairment of certain intangible assets, which together totalled USD 24.4 million.
Restructuring charges following the acquisitions of Sagem Mobiles software activities and Purple Labs totalled USD 9.9 million in the period. Management does not expect to record further restructuring charges for these acquisitions in the second half of 2009.
The Myriad Board of Directors decided to record a non-cash impairment charge in 2009 H1 to reduce the carrying value of goodwill and other intangible assets. The total impairment of USD 14.4 million includes USD 4.6 million against certain intangible assets in the Device Solutions segment and USD 9.8 million of goodwill in the Mobile Services Platforms segment.
Net Loss for the period was USD 29.1 million in 2009 H1, including the above one-time charges and further expenses related to financial results and taxes. Operating cash flow was positive in 2009 H1, growing to USD 2.7 million from USD -0.8 million in the prior year period.
Cash & cash equivalents as of 30 June 2009 was USD 21.7 million. The increase from USD 3.7 million at year-end 2008 resulted mainly from the USD 22.2 million net cash coming from the Purple Labs acquisition, and also reflects the positive operating cash flow in the period.
Information on Myriad’s Media and Analyst Briefing Today in Zurich, Myriad will present its H1 2009 results to members of the media and analysts.
Media & Analyst conference - 23 September 2009 9:00 a.m. CET SIX Swiss Exchange ConventionPoint, Zurich, Switzerland.
For more information please contact investor_relations@myriadgroup.com
The Financial Statements for the six-month period ended 30 June 2009 is available on the company’s website:
http://www.myriadgroup.com/Investors/Financial-Publications.aspx
Investor Calendar
Myriad will present Q3 2009 business update by 30 October 2009
Interim consolidated statements of operations
About Myriad
Myriad Group AG is a global leader in mobile technology and has shipped
software in more than 2 billion devices. Its comprehensive portfolio includes
browsers, messaging, Java, user interfaces and middleware for all types of mobile
phones, from ultra-low cost handsets to advanced smartphones.
The company provides both individual components and complete solutions, which
enable handset manufacturers and operators to deliver amazing experiences on
mobile phones. Myriad also develops USSD-based customer self-care platforms
that deliver over 10 billion messages a year to 220 million mobile users across
more than 33 mobile operators worldwide.
2009
-
08/01/2009
Ablynx strengthens management team with the appointment of Dr Debbie Law as Chief Scientific Officer
-
09/01/2009
CoreValve Prevails in United Kingdom Patent Infringement Action
- 13/01/2009
- 13/01/2009
- 14/01/2009
-
15/01/2009
ReVolt Technology, Ltd Receives Additional 10 Million Euro B Round Investment
- 16/01/2009
- 20/01/2009
-
21/01/2009
Ablynx expands its musculoskeletal portfolio by taking P&G pharmaceuticals' programme in-house
- 21/01/2009
-
21/01/2009
DBV Technologies raises €6 million (EUR) in Series B investment and secures new corporate investor
- 21/01/2009
- 22/01/2009
- 28/01/2009
- 28/01/2009
-
04/02/2009
Inside Contactless and Sagem Wireless extend NFC Technology Partnership
- 05/02/2009
-
11/02/2009
NFC Technology Part of Qualcomm 3G Handset Reference Designs,
-
13/02/2009
Esmertec to acquire Purple Labs creating Europe’s largest mobile phone software company
-
23/02/2009
Sofinnova Partners realizes impressive exit with sale of portfolio company CoreValve to Medtronic
- 23/02/2009
-
17/02/2009
Tech tour seeks 'Best of French' emerging technology companies
-
05/03/2009
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
- 05/03/2009
- 03/03/2009
- 03/03/2009
- 10/03/2009
- 12/03/2009
- 17/03/2009
-
25/03/2009
Sofinnova Partners Voted 2008 “European Venture Capital Firm of the Year”
-
25/03/2009
Sofinnova Partners élu « Société de capital-risque européenne de l'année 2008 »
-
30/03/2009
Ablynx reports detailed positive phase Ib results for its anti-thrombotic Nanobody® ALX-0081
-
31/03/2009
First Data and Inside Contactless launch partnership for go-tag payment sticker technology
- 02/04/2009
- 08/04/2009
-
15/04/2009
Travel technology leader Sprice.com to power Sify's travel search
- 20/04/2009
-
13/04/2009
PC 30 | ITÉLÉ 13 AVRIL 09 20H30-21H - Vive les entreprises de service ?
- 21/04/2009
- 27/04/2009
- 27/04/2009
- 29/04/2009
- 07/05/2009
- 11/05/2009
- 15/05/2009
-
27/05/2009
U.S. Bank first to offer a single visa card for identification, purchases and secure facility access
-
28/05/2009
Inside debuts converged contactless payment/access control platform
- 30/05/2009
- 02/06/2009
- 28/05/2009
- 02/06/2009
- 02/06/2009
-
08/06/2009
NOXXON Announces Initiation of First Clinical Trial with a Spiegelmer®
-
19/06/2009
ReVolt Technology Selected as a Top-24 European Cleantech Leader
- 18/06/2009
-
22/06/2009
blueKiwi lève 3 millions d'euros auprès de Dassault Systèmes
- 23/06/2009
- 22/06/2009
- 26/06/2009
- 29/06/2009
- 29/06/2009
-
02/07/2009
PC30 reprend les activités « desktop » de SOGETI en Ile de France
- 02/07/2009
-
06/07/2009
Blue Kiwi | The Europas Shortlist: Best Enterprise / B2B Startup
- 08/07/2009
-
09/07/2009
ReVolt Technology, Ltd & BASF Announce Joint Development Agreement for Rechargeable Zinc-Air Battery
- 09/07/2009
- 09/07/2009
-
15/07/2009
INTERAC® Partners with Global Leader INSIDE to bring Contactless Debit to Canada
- 27/07/2009
-
27/07/2009
Orange to offer free gifts to students who agree to receive ads on mobiles
-
21/07/2009
Multek Enhances Touch Screen Solution Through Sensitive Object Strategic Alliance
- 30/07/2009
-
30/07/2009
Renforcement du conseil de surveillance de PC30 Jean Marie Descarpentries nommé Président
-
13/08/2009
Inside Contactless and cryptography research sign agreement to license DPA patents
-
12/08/2009
Upek launches developer contest for Windows 7 Biometric applications
- 12/08/2009
-
18/08/2009
Orexo announces that its partner Meda has initiated the launch of EdluarTM in the USA
- 18/08/2009
-
18/08/2009
Myriad Delivers Services Platform for Customer Service to T-Mobile
- 27/08/2009
-
28/08/2009
Orexo signs exclusive worldwide license agreement for a novel formulation
- 27/08/2009
- 28/08/2009
- 01/09/2009
- 01/09/2009
- 03/09/2009
- 01/09/2009
-
08/09/2009
Inside Contactless and Connecthings team to take NFC to the next level
-
09/09/2009
ReVolt Technology named a Global Cleantech 100 clean technology company
- 09/09/2009
-
10/09/2009
SFR a sélectionné WYPLAY pour sa prochaine génération de décodeurs TV
- 10/09/2009
-
09/09/2009
Engel and Wyplay parnter for next generation connected HD STB
-
11/09/2009
Myriad Introduces World’s First Widget Solution for Ultra-Low Cost Mobile Phones
- 14/09/2009
-
14/09/2009
Addex' ADX10059 has potential for Parkinson's disease levodopa induced dyskinesia (PD-LID)
- 15/09/2009
-
22/09/2009
Myriad Appoints Former Nokia Chief Technologist Benoit Schillings as Chief Technical Officer
-
22/09/2009
UPEK Expands Biometric Market with Launch of New TouchChip® Fingerprint Solutions
-
23/09/2009
Myriad Group Reports EBITDA of USD 11 Million for 2009 H1
-
28/09/2009
Addex complète le recrutement d’un premiere essai clinique intermédiare sur le RGO
-
28/09/2009
Addex completes enrollment of first mid-stage clinical GERD trial
-
28/09/2009
Upek launches new product line optimized for mobile phone applications
- 01/10/2009
- 01/10/2009
-
01/10/2009
Sofinnova Partners announces an agreement to sell Fovea Pharmaceuticals to Sanofi Aventis
-
01/10/2009
Ablynx receives milestone payment as part of its strategic alliance with Boehringer Ingelheim
-
06/10/2009
PUMA partners with Sagem Wireless to launch PUMA Mobile Phone
- 06/10/2009
-
12/10/2009
Crescendo Biologics Raises £4.5 million in Seed-Funding Led by Sofinnova Partners
- 12/10/2009
-
12/10/2009
Ablynx and Domantis settle their dispute and stop the arbitration process
-
15/10/2009
Protector Suite 2009 Software Adds Support for Windows 7 and the Windows Biometric Framework
-
15/10/2009
MicroPass 5100 “ICAO Lite” Products Compete for Best Identification Solution
-
15/10/2009
Accent - Itron Selects Accent Single Chip Solution for Smart Metering Applications
-
16/10/2009
Flexion Therapeutics Raises $33 Million in Series A Financing
- 19/10/2009
-
21/10/2009
Largest Retail Deployment of Contactless Loyalty Sticker Technology in France
- 22/10/2009
- 23/10/2009
-
26/10/2009
Sofinnova Partners Leads $12 Million Series A Round in DNP Green Technology
- 26/10/2009
- 27/10/2009
-
27/10/2009
Sagem Wireless collaborates with CRYSTALLIZED™ – Swarovski Elements
-
03/11/2009
Addex Presents ADX10059 PD-LID Data at GPCR Drug Discovery Conference
- 03/11/2009
- 02/11/2009
- 02/11/2009
-
16/11/2009
Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial
-
18/11/2009
Ablynx achieves third milestone in drug discovery and development collaboration
- 17/11/2009
-
19/11/2009
INSIDE Contactless wins in Semiconductor, Electronic and Components Category
-
03/12/2009
Movetis raises targeted €85 million in successful Initial Public Offering on Euronext Brussels
- 04/12/2009
-
03/12/2009
NOXXON Pharma AG Achieves Milestone in Partnership with Eli Lilly and Company
- 03/12/2009
-
03/12/2009
Addex Extends Parkinson's Disease Collaboration with Merck & Co., Inc.
- 08/12/2009
- 04/12/2009
- 02/11/2009
- 14/12/2009
-
14/12/2009
Addex ends migraine prevention study Conference call tomorrow at 2pm CET (8am ET)
-
23/12/2009
Sofinnova Partners annonce sa troisième cession de plus de 500 millions de dollars pour l’année 2009
- 23/12/2009
-
26/11/2009
MasterCard Canada Brings PayPass™ Payments to BlackBerry Smartphones
-
23/12/2009
Sofinnova Partners Announces for the Third Time in 2009 a Trade Sale over 500 million dollars
-
23/12/2009
Movetis raises a total of €97.75m via an additional €12.75 million Over-allotment Option
-
22/12/2009
Ablynx demonstrates proof-of-concept by biomarker for its anti-thrombotic ALX-0081